Most studies have shown that many cancer patients are at high risk of developing severe forms of COVID-19. In a study of nearly 900 cancer patients with coronavirus in the UK, for instance, the death rate was estimated to be 33.6%, which is much higher than the general population. However, most of these patients were […]
In a major report, the NHS proposing to radically overhaul diagnostic services for patients, including MRI, CT and blood tests. The NHS is to set up diagnostic hubs, or ‘one stop shops’ across the country and away from hospitals. This will enable patients to be diagnosed closer to home. These community centres could be set […]
A report from NHS England has found that the COVID-19 pandemic has identified a need for a ‘radical change’ in diagnostic services across the country. This report was close to publication before the pandemic identified additional actions needed to deliver higher quality diagnostic services. As part of this ‘radical change’ NHS England identified a number […]
In this video interview, Professor Thomas Powles, Director of London’s Barts Cancer Centre discusses the impact of the ongoing COVID-19 pandemic on cancer care in the United Kingdom. Dr Powles details how temporary protective measures set in place at Barts in the early months of the pandemic, such as temperature checks and limited visitors, have […]
In this article published in Cancer Therapy Advisor this week, changes to how clinical trials are being conducted due to the health risks posed by COVID-19 to cancer patients are discussed. Some of these changes include the use of telemedicine visits, electronic signatures for signing patient consent forms, posting oral medicines to patients’ homes, and […]
Research from University College London published in PLOS One estimated that at the peak of the COVID-19 pandemic, clinical research capacity may have been slashed by up to 87% in England. The researchers estimated that at a population infection rate of 10% (the peak in April for over a month) less than 400 of the […]
COVID-19 continues to affect the care of patients with metastatic renal cell carcinoma (RCC) and other cancers in a number of ways. Oncologists are learning as much as possible about the virus to make the best treatment decisions possible for their patients. One of the activities put in place is the COVID-19 and Cancer Consortium […]
The Government in Scotland has published a new plan to remobilise NHS cancer care to put the experience of patients at its heart. It will focus on improving services and ensuring that all patients have access to the best possible treatments. The coronavirus (COVID-19) pandemic has resulted in significant changes to the war cancer services […]
The European Society for Medical Oncology (ESMO) has released a consensus statement about the management of cancer patients during the COVID-19 pandemic. An international consortium was established to discuss clinical evidence and to provide expert advice. The steering committee addressed significant clinical questions from diagnosis to surgery. The statements were discussed and voted upon The […]
There is a lot of ongoing research to understand the effect of cancer and its treatment on the outcomes of patients who contract COVID-19. Cancer patients could be at greater risk from COVID-19 because their immune systems are suppressed or they have other conditions due to their cancer or its treatment. Cancer patients are also […]
Copyright 2017 Kidney Cancer Support Network- Douglass Digital | Cambridge Web Design
